Stephanie Joi Lee

Stephanie Lee practices at Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center.

Stephanie Lee's NPI, 1427138494, was assigned on October 16, 2006. Stephanie Lee graduated from Stanford University School of Medicine in 1990. Stephanie Lee holds Washington license MD00045746.

Stephanie Lee's primary practice is Fred Hutchinson Cancer Center, at 825 Eastlake Avenue East, Seattle, WA 98109.

Stephanie Lee's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center. The medical group on file is UW Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Stephanie Lee practices. Vendor and product names are available with a free account.

Hematology and oncology is Stephanie Lee's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Stephanie Lee is licensed in Washington.

CMS data shows 56 Medicare services from Stephanie Lee across 2 procedure codes in 2024, for 19 Medicare patients. Medicare paid $3,030 for them. Every service was in an office.

CMS counts 19 Medicare patients who saw Stephanie Lee in 2024. The largest group is 85 and over, with 0 patients. 68% of them have high cholesterol. Their average risk score is 2.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Stephanie Lee's median patient age at 63, with 43% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Stephanie Lee for performance year 2024, reported through an alternative payment model (APM). Stephanie Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 22 papers to Stephanie Lee, published from 2018 to 2025. 2025 was the busiest year, with 15. The most frequent topics are Hematopoietic Stem Cell Transplantation, Graft vs Host Disease and Hematologic Neoplasms. Stephanie Lee has published most often in Transplant Cell Ther. Stephanie Lee's most frequent co-authors are Rohtesh S. Mehta, MD, MPH, Corey S. Cutler, MD and Hermioni L. Amonoo, MD.

CMS Open Payments shows 132 general payments to Stephanie Lee from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 38% of the total. Mallinckrodt LLC paid the most, $24,399. It also lists 2 research payments totaling $2,500 in 2025, naming 2 clinical trials.

Stephanie Lee graduated from Stanford University School of Medicine in 1990.